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Abstract: Copper amine oxidases (CAOs) are a ubiquitous group of enzymes that catalyze 
the conversion of primary amines to aldehydes coupled to the reduction of O2 to H2O2. 
These  enzymes  utilize  a  wide  range  of  substrates  from  methylamine  to  polypeptides. 
Changes  in  CAO  activity  are  correlated  with  a  variety  of  human  diseases,  including 
diabetes  mellitus,  Alzheimer’s  disease,  and  inflammatory  disorders.  CAOs  contain  a 
cofactor,  2,4,5-trihydroxyphenylalanine  quinone  (TPQ),  that  is  required  for  catalytic 
activity and synthesized through the post-translational modification of a tyrosine residue 
within the CAO polypeptide. TPQ generation is a self-processing event only requiring the 
addition of oxygen and Cu(II) to the apoCAO. Thus, the CAO active site supports two very 
different  reactions:  TPQ  synthesis,  and  the  two  electron  oxidation  of  primary  amines. 
Crystal structures are available from bacterial through to human sources, and have given 
insight into substrate preference, stereospecificity, and structural changes during biogenesis 
and catalysis. In particular both these processes have been studied in crystallo through the 
addition of native substrates. These latter studies enable intermediates during physiological 
turnover  to  be  directly  visualized,  and  demonstrate  the  power  of  this  relatively  recent 
development in protein crystallography. 
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Abbreviations:  Arthrobacter  globiformis  amine  oxidase  (AGAO);  Aspergillus  nidulans  amine 
oxidase (ANAO); precursor form of copper amine oxidase (apoCAO); bovine serum amine oxidase 
(BSAO); copper amine oxidase (CAO); cysteine tryptophylquinone (CTQ); diamine oxidase (DAO); 
dopaquinone (DPQ); Escherichia coli amine oxidase (ECAO); Hansenula polymorpha amine oxidase 
that prefers small aliphatic primary amines (HPAO-1); Hansenula polymorpha amine oxidase that 
prefers aromatic primary amines (HPAO-2); ligand-metal charge transfer (LMCT); lysyl oxidase (LOX); 
lysyl oxidase-like proteins (LOXL); lentil seedling amine oxidase (LSAO); lysyl tyrosylquinone (LTQ); 
monoamine oxidase (MAO); Protein Data Bank (PDB); pyridoxal phosphate (PLP); potential of mean 
force (PMF); Pichia pastoris lysyl oxidase (PPLO); pyrroloquinoline quinone (PQQ); Pisum sativum 
amine oxidase (PSAO); root-mean-square deviation (rmsd);  semicarbazide-sensitive amine oxidase 
(SSAO);  2,4,5-trihydroxyphenylalanine  quinone  (topaquinone  or  TPQ);  2,4-dihydroxy-5-
aminophenylalanine  (aminoquinol  or  TPQamq);  2,4,5-trihydroxyphenylalanine  (TPQred);  tryptophan 
tryptophylquinone (TTQ); vascular adhesion protein-1 (VAP-1) 
1. Introduction 
Amine oxidases are responsible for the oxidative deamination of amines to their corresponding 
aldehydes sequentially coupled to the reduction of O2 to H2O2. Members of this ubiquitous group of 
enzymes can be further classified based on the chemical identity of the organic cofactor used during 
catalysis, into either the flavin adenine dinucleotide-containing amine oxidases (monoamine oxidase 
(MAO) (E.C. 1.4.3.4) and polyamine oxidase (E.C. 1.5.3.17)) or the copper/quinocofactor-containing 
amine oxidases. MAOs are found exclusively in the outer mitochondrial membrane of mammalian 
cells, and catalyze the deamination of primary, secondary, or tertiary amines. These flavoproteins have 
a  firmly  established  role  in  the  metabolism  of  aminergic  neurotransmitters  such  as  serotonin, 
norepinephrine, epinephrine, and dopamine [1]. Polyamine oxidases preferentially oxidize polyamines 
such as spermine and spermidine, and play a role in the regulation of cellular growth [2]. 
In contrast, the copper/quinocofactor-containing amine oxidases are active against only primary 
amines, and possess one of two quinone-containing cofactors: 2,4,5-trihydroxyphenylalanine quinone 
(topaquinone or TPQ) or lysyl tyrosylquinone (LTQ). Although the TPQ- and LTQ-containing amine 
oxidases both oxidatively deaminate primary amines through the use of an organic quinone-containing 
cofactor and a copper ion, these two enzyme families are non-homologous. LTQ is found in the lysyl 
oxidase (LOX)-like family of proteins (LOXL, E.C. 1.4.3.13), named for their ability to convert the  
ε-amino group of peptidyl lysine residues to an aldehyde. This peptidyl aldehyde product can condense 
with a neighboring lysine residue or react with a second lysine-derived aldehyde to form crosslinks 
important in the formation and stabilization of collagen and elastin [3]. Amine oxidases containing 
TPQ (CAOs for copper-containing amine oxidases, E.C. 1.4.3.21) were the first to be characterized in 
a growing number of bifunctional enzymes that contain ―home-made‖ cofactors produced in situ by 
the post-translational modification of an endogenous amino acid side chain [4]. This review focuses on 
cofactor biogenesis and catalysis in the TPQ-containing CAOs, with a particular emphasis on the role 
X-ray crystallography has played in understanding these two processes. 
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2. Physiological Significance of CAOs 
In the decades since the first discovery of amine oxidase activity in the blood plasma of sheep in 
1929 [5], CAOs have been found to exist almost ubiquitously in aerobic organisms, taking on a myriad 
of  functional  roles  depending  on  enzyme  source,  cellular  location,  and  physiological  substrate.  
In bacteria and  yeast,  CAOs  are thought  to play  mainly a catabolic role, allowing for the use of 
primary amines as a sole carbon and/or nitrogen source for cellular growth [6,7]. 
In eukaryotes these enzymes have more poorly defined roles but are known to contribute to a 
variety of complex cellular activities. CAO activity helps regulate several processes in plants due to 
the  compartment-specific  production  of  product  H2O2,  which  affects  plant  germination,  seedling 
establishment, and root growth [8]. Hydrogen peroxide production is also associated with cell wall 
maturation and lignification during growth, as well as wound-healing and the reinforcement of cell 
walls during cellular stress due to pathogenic attack [9,10]. Moreover, amine catabolism is known to 
influence the plant stress response upon exposure to cadmium or excess salt [11]. 
Several CAO homologs are expressed in mammalian tissues. In order to study their distribution 
amongst mammalian species, four complete genes (AOC1–4, for ―amine oxidase, copper-containing‖) 
were cloned and characterized from porcine genomic DNA. All of these encode a bona fide CAO 
which displays catalytic activity toward primary amines [12]. These were used to identify orthologs in 
other mammalian genomes; all four AOC genes have been identified in cows, horses, dogs, mice, rats, 
chimpanzees,  macaques,  and  humans  [12].  AOC1  encodes  a  soluble  secretory  enzyme  known  as 
diamine oxidase (DAO) [13], AOC2 encodes a retina-specific amine oxidase [14], and AOC3 encodes 
an endothelial vascular adhesion protein (known as VAP-1 in humans) [15]. AOC4 was found to 
encode  an  additional  serum/plasma  CAO  homologous  to  VAP-1,  which  lacks  the  N-terminal 
transmembrane  domain  found  in  VAP-1.  However,  the  AOC4  gene  in  humans  is  truncated  and 
nonfunctional due to an internal stop codon, and Aoc4 encoded by rodent genomes is present only in 
small fragments [12]. 
In  mammals,  nearly  all  biogenic  primary  amines  can  act  as  CAO  substrates,  including  the 
neurotransmitters serotonin, norepinephrine, epinephrine, and dopamine. A large number of additional 
amines have been identified as CAO substrates, including methylamine, ethylamine, aminoacetone, 
benzylamine,  phenylethylamine,  agmatine,  spermine,  spermidine,  histamine,  tyramine,  mescaline, 
putrescine, and cadaverine [16–18]. 
Members of the CAO protein family contribute to the regulation of a myriad of complex processes 
in mammals due to the diversity in their substrates, their wide distribution throughout mammalian 
tissues (including the brain, blood plasma, kidneys, placenta, and throughout the cardiovascular and 
gastrointestinal  systems),  and  changes  in  expression  and  activity  during  disease  and  throughout 
pregnancy  [19].  For  example,  histamine,  a  pro-inflammatory  amine  produced  by  mast  cells  upon 
allergic reaction or cellular damage, is cleared in human tissues by DAO [20]. Tumor cells are known 
to  contain higher concentrations  of amines than cells  from normally proliferating tissues,  and  the 
oxidation of spermine or spermidine by CAOs produces acrolein, a known cytotoxin which can induce 
cellular death in cancerous tissues [21]. Agmatine (produced from the decarboxylation of arginine) 
binds to the α2 adrenergic receptor and imidazoline binding sites; its regulation through CAO activity 
has been shown to modulate withdrawal anxiety in rats [22]. Int. J. Mol. Sci. 2012, 13  5378 
 
 
Changes  in  CAO  activity  are  correlated  with  a  variety  of  human  diseases,  including  diabetes 
mellitus, Alzheimer’s disease, and additional inflammatory disorders [23]. A truncated soluble form of 
membrane-bound  VAP-1  known  as  semicarbazide-sensitive  amine  oxidase  (SSAO)  is  known  to 
mediate glucose uptake  in  adipocytes  via the recruitment  of the glucose transporter GLUT4 from 
vesicles within the cellular interior to the cell surface [24]. The soluble SSAO may also compensate for 
the absence of the Aoc4 product in humans. VAP-1 also controls leukocyte extravasation to sites of 
inflammation  through  its  activity  against  amine  groups  from  solvent-exposed  lysine  residues  of 
membrane-associated counter-receptors, including sialic acid binding Ig-like lectins (siglecs) [15,25]. 
Mice deficient in Aoc3 expression exhibit impaired immune responses, but notably present no other 
detectable phenotypic changes [26]. The highly reactive aldehydes produced from the oxidation of 
methylamine  and  aminoacetone  in  human  tissues  contribute  to  protein  cross-linking,  β-amyloid 
aggregation, and advanced glycation end-product formation in patients with Alzheimer’s disease or 
diabetes mellitus [27,28]. With CAO activity playing a critical role in such numerous and diverse 
physiological processes, ranging from basic metabolism in bacteria and yeast to roles in multifaceted 
disease states in humans, an understanding of TPQ production and catalysis in these enzymes is critical 
to the development of any potential pharmaceutical therapies which may regulate their activity [23]. 
3. Post-Translationally Modified Amino Acid Cofactors 
A large number of enzymes require low-molecular weight cofactors for catalytic activity, some of 
which are covalently attached to the protein component. Most cofactors are non-proteinaceous and 
independently synthesized before their association with the protein component of the relevant enzyme. 
However, it is now well-established that some enzymes utilize the post-translational modification of 
endogenous amino acid side chains to form cofactors in situ [4]. This approach enables an enzyme to 
avoid the energetic costs of cofactor import both to and within the protein, and furthermore may 
sequester potentially deleterious intermediates produced during cofactor formation. For example, TPQ 
as a free molecule is a known neurotoxin, however its production from an endogenous tyrosine residue 
in the deeply buried CAO active site circumvents this problem [29]. Most importantly, this strategy 
increases  the  diversity  of  chemical  properties  available  within  an  enzyme  active  site  beyond  that 
afforded by the twenty canonical amino acids. 
Variations in both the physical properties of these modified amino acid cofactors as well as the 
mechanisms  employed  for  their  formation  are  widespread.  Many  modifications  involve  the 
crosslinking of two amino acid side chains, for example cytochrome c oxidase and catalase (Tyr-His); 
tyrosinase, hemocyanin, and catechol oxidase (His-Cys); and galactose oxidase (Tyr-Cys) [30–36]. 
Cofactor biosynthesis can also involve the modification of a single side chain: sulfatases (cysteine 
converted to formylglycine); rubisco, urease, and phosphotriesterase (carbamylation of a lysine residue); 
NADH  peroxidase,  NADH  oxidase,  and  nitrile  hydratase  (cysteine  converted  to  cysteinesulfenic  
acid) [37–43]. 
Several additional enzymes undergo post-translational modification of an endogenous tyrosine or 
tryptophan residue to form cofactors which contain a quinone moiety. To date, these include TPQ in 
CAO  (Figure  1A)  [29],  LTQ  in  LOXL  (Figure  1B)  [44],  tryptophan  tryptophylquinone  (TTQ)  in 
bacterial amine dehydrogenase (Figure 1C) [45], and cysteine tryptophylquinone (CTQ) in bacterial Int. J. Mol. Sci. 2012, 13  5379 
 
 
quinohemoprotein amine dehydrogenase (Figure 1D) [46]. 
Figure 1. Quinone-containing cofactors formed by the post-translational modification of 
tyrosine or tryptophan side chains. 
 
The  first  of  these  four  quinocofactors  to  be  identified  was  TPQ,  which  is  located  in  the  
deeply-buried CAO active site. The formation of a chromophoric complex between CAO proteins and 
hydrazine derivatives had originally suggested pyridoxal phosphate (PLP) as a likely candidate for the 
CAO cofactor (Figure 2A) [47]. Two independent studies later reported the cofactor in Bos taurus 
serum  amine  oxidase  (BSAO)  to  be  covalently-bound  pyrroloquinoline  quinone  (PQQ)  [48,49]  
(Figure 2B), which was strengthened by resonance Raman experiments conclusively eliminating PLP 
as  a  possible  CAO  cofactor  [50,51].  The  true  identity  of  the  CAO  cofactor  was  unequivocally 
confirmed  to  be  topaquinone  (Figure  1A)  by  Janes  et  al.  through  the  use  of  mass  spectrometry, 
ultraviolet-visible spectroscopy, and proton NMR studies of a pentapeptide isolated from proteolyzed 
BSAO in comparison to a peptide analog of 6-hydroxydopa [29]. 
Figure 2. Structures of initially proposed CAO cofactors (A) PLP and (B) PQQ. 
 
4. Overall CAO Fold 
The  structures  of  CAOs  isolated  from  a  variety  of  organisms  have  been  solved  by  X-ray 
crystallography  (Table  1).  Despite  sharing  only  20–40%  sequence  homology,  they  all  adopt  an 
archetypal fold which brings together a number of conserved residues to form the CAO active site Int. J. Mol. Sci. 2012, 13  5380 
 
 
where both cofactor biogenesis and catalysis take place. There are currently no crystal structures of 
LTQ-containing LOXL proteins, which are non-homologous to the TPQ-containing CAOs. 
Table 1. TPQ-containing CAOs with available X-ray crystal structures. 
Source  Organism  Reference 
Mammalian  Homo sapiens  
Bos taurus 
VAP-1/SSAO [52,53]; DAO [20]; 
BSAO [54] 
Yeast  Hansenula polymorpha  
Pichia pastoris 
HPAO-1 [55]; HPAO-2 [56]  
PPLO [57] 
Bacterial  Arthrobacter globiformis 
Escherichia coli 
AGAO [58] 
ECAO [59] 
Plant  Pisum savitum  PSAO [60] 
Fungal  Aspergillus nidulans  ANAO [61] 
All  CAOs  structurally  characterized  thus  far  are  homodimeric,  with  individual  protein  subunit 
masses ranging from ~70–80 kDa and eukaryotic CAOs having additional mass through glycosylation. 
The CAO monomer can be divided into four domains (D1–D4) organized along its primary sequence. 
The shape of the CAO dimer is similar to that of a mushroom, with the amino-terminal domain D1 
(present  only  in  the  ECAO  crystal  structure)  acting  as  a  ―stalk‖  (not  present  in  HPAO-1,  
Figure 3) [59]. D2 and D3 are small α/β domains composed of ~100 residues each, and are thought to 
have arisen from a gene duplication event given their sequence homology and near identical topology 
(in HPAO-1, alignment of equivalent D2 and D3 main chain atoms gives a root-mean-square deviation 
(rmsd) of ~1.1 Å [55]) (purple (D2) and green (D3) in Figure 3). 
Figure 3. Overall fold of HPAO-1 viewed along the molecular dyad axis. One monomer is 
drawn in cartoon, and colored by domain (D2: purple; D3: green; D4: blue; connecting 
loop: yellow; β-hairpin arms: red). The second monomer is drawn as a semi-transparent 
molecular  surface  colored  grey.  TPQ  from  both  monomers  are  drawn  as  space-filling 
spheres and colored by atom type (carbon, grey). 
 
The large carboxy-terminal domain D4 is composed of ~500 residues and contributes the majority 
of the conserved amino acids which form the enzyme active site (blue in Figure 3). The topology of D4 
is that of a complex antiparallel β-sheet sandwich structure. Two β-hairpin arms protrude from the D4 
domains of each monomer, which contain amino acid residues that interact with its partner in the Int. J. Mol. Sci. 2012, 13  5381 
 
 
protein dimer and form a portion of the back wall of the other monomer’s active site (red in Figure 3). 
These arms are thought to be important for the maintenance of dimer stability as well as the regulation 
of substrate specificity in CAOs. The region between monomers encloses a solvent-filled cavity known 
as the ―inland lake,‖ and the dimer interface is extensive with a buried surface area comprising ~20% 
of the total surface area [58,59] (Figure 3). 
All structurally characterized CAOs besides HPAO-1 and -2 contain two metal binding sites distinct 
from the active site copper, one of which is solvent exposed and one of which is less accessible (~36 Å 
and ~30 Å from the active site in ECAO, respectively) [62]. These metal sites primarily bind Ca(II), 
with the plant CAOs binding Ca(II) or Mn(II) at the less accessible site dependent on the availability of 
divalent metal ions [60,63]. The X-ray crystal structures of HPAO-1 and -2 indicate a salt bridge at the 
corresponding position (HPAO-1: Glu69 and Arg467, HPAO-2: Lys42 and Asp445) [55,56]. A study 
conducted using EDTA-treated ECAO found that calcium binding at these two sites is not essential for 
activity, but its removal decreases catalytic efficiency by ~60–90%, which can be partially recovered 
by the addition of an exogenous divalent cation [62]. This effect has been attributed to long-range 
structural changes which either alter the conformation of TPQ, or affect the dynamics of a hydrophobic 
channel important for oxygen transport to the active site. 
5. Structure of the CAO Active Site 
The deeply buried CAO active site contains a mononuclear type 2 Cu(II) ion bound in a distorted 
square pyramidal geometry by the imidazole groups of three conserved histidine residues at a distance 
of ~2.0 Å, a well-ordered axial water ligand at a distance of ~2.4 Å (Wa), and a more labile equatorial 
water ligand visualized in some CAO structures at a distance of ~2.0 Å (We) (Figure 4A). TPQ has 
been visualized in two conformations that are named based on the relationship between TPQ and the 
bound copper ion. The ―off-copper‖ TPQ conformers do not act as copper ligands; instead, the O2 
atom interacts with the metal center via the conserved axial water molecule (Figure 4A). The oxygen 
atom at position 4 of the TPQ ring is involved in a short hydrogen bond (~2.3 Å) with the phenolic 
hydroxyl of a conserved active site tyrosine residue (Tyr305 in HPAO-1). As this distance is less than 
2.5 Å, it indicates a shared proton between Tyr305 and TPQ. The side chain of Tyr305 also interacts 
with the axial water ligand (Wa) via an intervening water molecule (W1 in Figure 4A). The carbonyl 
group at position 5 of the TPQ ring points away from the copper center and toward the amine substrate 
channel. This off-copper species represents a catalytically productive CAO active site, as the C5 atom 
is the site of nucleophilic attack by amine substrates. A conserved aspartate residue, which acts as a 
general base during catalysis, sits near the substrate binding pocket (Asp319 in HPAO-1), with an 
intervening  water  molecule  between  it  and  the  cofactor  (W2  in  Figure  4A).  TPQ  can  also  adopt  
an ―on-copper‖ conformation, in which the ring has rotated about its Cα-Cβ and Cβ-Cγ bonds. In this 
conformation, TPQ displaces the axial water molecule which is coincident with the off-copper TPQ 
conformer  (Wa)  and  instead  interacts  directly  with  copper  via  its  O4  atom.  This  represents  an 
unproductive  state  because  the  C5  atom  of  TPQ  is  inaccessible  for  nucleophilic  attack  by  
substrate (Figure 4B). Int. J. Mol. Sci. 2012, 13  5382 
 
 
Figure 4. Crystal structures of the HPAO-1 active site (PDB code 2oov) with TPQ in an 
(A) ―off-copper‖ or (B) ―on-copper‖ conformation [55,64]. Residues are drawn in stick and 
colored by atom type (carbon, grey). Copper ions are drawn as gold spheres, and water 
molecules are drawn as small red spheres. Hydrogen bonds are indicated by dashed lines, 
and metal-ligand interactions are indicated by solid lines. In (B), the ―off-copper‖ TPQ 
conformer from panel (A) is drawn in semi-transparent stick. 
 
6. Biogenesis of TPQ 
The mechanism by which fully-folded CAOs synthesize a quinone-containing cofactor in situ has 
been an intriguing question in the field. A number of biochemical studies first established the process 
to  be  autocatalytic,  requiring  copper  and  oxygen  but  no  auxiliary  enzymatic  activity  or  reducing 
equivalents  [65,66].  Two  moles  of  O2  are  consumed  for  every  mole  of  TPQ  and  H2O2  produced 
(Scheme 1) [67]. 
Scheme  1.  An  endogenous  tyrosine  residue  is  converted  to  TPQ  in  an  autocatalytic 
oxygen- and copper-dependent process. E represents the enzyme polypeptide. 
 
Kinetic  and  structural  investigations  using  metal-free  precursor  (apo)  protein  from  Hansenula 
polymorpha (apoHPAO-1) and Arthrobacter globiformis (apoAGAO), the only metal-free precursor 
CAO proteins currently available, have led to a proposed mechanism for TPQ biogenesis. This process 
in  HPAO-1  is  outlined  in  Scheme  2.  ApoCAO  is  defined  as  amine  oxidase  protein  which  lacks  
both  active  site  cofactors:  a  mononuclear  copper  ion  and  TPQ.  The  tyrosine  residue  which  
undergoes  modification  is  contained  within  the  conserved  active  site  consensus  sequence  
Thr-X-X-Asn-Tyr-Asp/Glu (precursor tyrosine residue underlined) [68]. TPQ biogenesis begins with 
apoCAO, in which the precursor tyrosine side chain is unmodified (A in Scheme 2) [58,69]. Copper Int. J. Mol. Sci. 2012, 13  5383 
 
 
binds at the active site, and is ligated by three strictly conserved histidine residues (A→B in Scheme 2). 
A kinetic study conducted using apoHPAO-1 with and without pre-bound copper reported a rate of 
TPQ formation which was unchanged with the pre-binding of Cu(II), indicating that copper binding is 
a fast process relative to the overall rate of biogenesis [70]. 
In  HPAO-1,  molecular  oxygen  then  binds  in  a  nearby  off-copper  hydrophobic  pocket,  which 
induces a conformational change in the precursor tyrosine side chain such that its hydroxyl group 
becomes oriented toward the copper (B→C in Scheme 2). Structural work suggests that at this point, 
the tyrosine residue is present in its protonated form, as indicated by the long distance between the 
phenolic  oxygen  and  bound  copper  in  crystal  structures  of  anaerobic  Cu(I)-apoHPAO-1  and  
Cu(II)-apoAGAO complexes (~2.8 Å and ~2.5 Å, respectively) [69,71]. 
Support  for  the  oxygen-dependent  formation  of  a  tyrosine/copper  complex  comes  from 
spectroscopic studies  carried out using apoHPAO-1  [72]. The pre-incubation of  apoHPAO-1 with 
copper  followed  by  exposure  to  molecular  oxygen  resulted  in  a  feature  which  absorbs  at  
λmax = 350 nm. This species decays isosbestically with the formation of TPQ, as indicated by a broad 
feature absorbing at 480 nm. Importantly, oxygen was found to be required but not consumed during 
this process, suggesting that oxygen binding results in a conformational change in the side chain of the 
precursor tyrosine residue. This movement, followed by deprotonation of the tyrosine, results in the 
formation of a ligand-metal charge transfer (LMCT) species which gives rise to the feature at 350 nm 
(C  in  Scheme  2).  A  putative  oxygen  binding  pocket  comprised  of  residues  Met634,  Tyr407,  and 
Leu425 has been identified in HPAO-1, and the rate of biogenesis is linked to the volume of the 
hydrophobic residue at position 634 [73,74]. 
Scheme 2. Proposed TPQ biogenesis mechanism in HPAO-1. Figure adapted from [70]. 
 
The Cu(II)-tyrosine complex, along with its Cu(I)-tyrosyl radical resonance form (D in Scheme 2), 
is activated for monooxygenation at position 3 of the tyrosine ring by the pre-bound O2, which forms a Int. J. Mol. Sci. 2012, 13  5384 
 
 
bridged peroxo adduct (C/D→E in Scheme 2). This species rapidly collapses to produce dopaquinone 
(DPQ)  (E→F  in  Scheme  2).  The  DPQ  ring  flips  ~180°  about  its  Cα-Cβ  bond  by  an  unknown 
mechanism (F→G in Scheme 2), which leaves it positioned for the incorporation of a second oxygen 
atom  at  position  6  of  the  ring  by  a  copper-activated  water/hydroxyl  (G→H  in  Scheme  2).  This 
produces TPQred (2,4,5-trihydroxyphenylalanine = 2-electron reduced TPQ) (H in Scheme 2), which is 
then  oxidized  to  mature  TPQ  with  the  concomitant  reduction  of  molecular  oxygen  to  hydrogen 
peroxide (H→I in Scheme 2). Lastly, TPQ moves to the catalytically productive off-copper position 
seen in structures of native CAO (I in Scheme 2). 
The  preceding  mechanism  is  strongly  supported  by  a  crystallographic  investigation  of  TPQ 
biogenesis in apoAGAO [69]. The crystal structure of apoAGAO has been solved to a resolution of  
2.2 Å, and unambiguously shows the precursor tyrosine residue (Y382 in AGAO) in its unmodified 
form with its hydroxyl group pointed toward the vacant metal binding site [58] (Figure 5A). This 
residue and the three conserved active site histidine residues that ligate copper in the native enzyme 
(His431, His433, and His592) are arranged around the empty metal binding site as if in a tetrahedral 
geometry. His431 and His433 adopt the conformers seen in the native enzyme, but His592 is present 
as  two  conformers,  indicating  some  positional  flexibility  at  this  site.  The  two  water  molecules 
normally observed in the native CAO active site which ligate the copper (Wa and We in Figure 4A) are 
absent in the apoAGAO structure. 
A series of crystal structures containing AGAO biogenesis intermediates were solved by exposing 
anaerobic apoAGAO crystals, which had been pre-bound with Cu(II), to O2 followed by freezing after 
different  amounts  of  time  [69].  This  study  produced  structures  of  an  anaerobic  complex  between 
apoAGAO and Cu(II) (flash-frozen after 0 min of O2 exposure), an early intermediate (flash-frozen 
after 10 min of O2 exposure), and a late intermediate (flash-frozen after 100 min of O2 exposure) 
formed during biogenesis (Figure 5B,C,D), which are consistent with the mechanism presented in 
Scheme 2.  Finally, exposure of apoAGAO to  O2 for a week before flash-freezing  resulted in the 
structure of a species identical to holoAGAO, confirming that biogenesis can go to completion in the 
crystal (Figure 5E). 
The structure of the anaerobic complex between apoAGAO and Cu(II) was solved to a resolution of 
1.9 Å (Figure 5B). The electron density clearly shows the unmodified side chain of Tyr382, consistent 
with  the  requirement  of  molecular  oxygen  for  TPQ  biogenesis.  The  phenolic  group  of  Tyr382  is 
thought to be protonated based on the distance between its hydroxyl  group and the bound copper  
(~2.5 Å). Aside from the bound copper ion, this structure is essentially identical to that of apoAGAO 
(Figure 5A), and represents the first step of TPQ biogenesis, activating the precursor tyrosine side 
chain for monooxygenation at position 3 of the phenyl ring. Int. J. Mol. Sci. 2012, 13  5385 
 
 
Figure  5.  Structurally  characterized  TPQ  biogenesis  intermediates  in  AGAO  [58,69]:  
(A)  apoAGAO  (PDB  code  1avk);  (B)  apoAGAO/Cu(II)  complex  (PDB  code  1ivu);  
(C) dopaquinone (DPQ)-containing early intermediate (PDB code 1ivv); (D) 2-electron 
reduced TPQ (TPQred)-containing late intermediate (PDB code 1ivw) and (E) holoAGAO 
generated in the crystal (PDB code 1ivx). Residues are drawn in stick and colored by atom 
type (carbon, grey). Copper ions are drawn as gold spheres, and water molecules as small 
red  spheres.  Solid  lines  indicate  metal-ligand  interactions,  and  dashed  lines  indicate 
hydrogen bonds. 
 
The structure of apoHPAO-1 in complex with Zn(II) (PDB code 1ekm) solved to 2.5 Å resolution 
in the presence of oxygen, reinforces the importance of the tyrosyl/copper complex in activating the 
precursor tyrosine ring for the initial oxygenation reaction [75]. Zinc is known to bind tightly at the 
CAO active site and resist displacement by copper [76]. Because zinc cannot support TPQ production, 
the structure of the Zn(II)-apoHPAO-1 complex mimics the copper bound species (B in Scheme 2). 
Similar to the anaerobic Cu(II)-apoAGAO complex, zinc was found to bind at the copper binding site 
and  was  ligated  by  the  three  conserved  histidine  residues  and  the  unmodified  precursor  tyrosine 
residue in a tetrahedral geometry [75]. 
A crystal structure containing the dopaquinone intermediate formed during TPQ biogenesis (F in 
Scheme 2) was solved to a resolution of 2.1 Å (Figure 5C) [69]. The electron density confirmed that in 
this intermediate one oxygen atom had been inserted into the ring of Tyr382 to form dopaquinone. An 
additional feature of this structure is the presence of an equatorial water ligand at a distance ~2.1 Å 
from the copper center (We in Figure 5C) that is absent in the anaerobic complex between apoAGAO 
and Cu(II) (Figure 5B). Int. J. Mol. Sci. 2012, 13  5386 
 
 
Freezing apoAGAO crystals after exposure to O2 for 100 minutes trapped TPQred (H in Scheme 2) 
solved to a resolution of 1.9 Å (Figure 5D) [69]. As indicated by the electron density, two oxygen 
atoms had been inserted into the Tyr382 ring, forming either TPQred or TPQ. This intermediate is 
formed only after rotation of the dopaquinone ring by ~180° , resulting in a species in which the O4 
atom acts as a direct ligand to the bound copper. Single crystal microspectrophotometry experiments as 
well as the presence of a hydrogen bond between the O2 atom of the ring with the backbone carbonyl 
of  Thr403  (indicating  that  the  O2  atom  is  protonated),  confirmed  that  this  species  is  TPQred  and  
not TPQ [69]. 
It was previously thought that only copper, the physiological relevant metal in CAOs, could support 
TPQ biogenesis. Studies conducted with apoHPAO-1 and apoAGAO, however, have revealed that 
biogenesis is supported by alternate metals in vitro, although at decreased rates [77,78]. In apoHPAO-1, 
biogenesis is supported by Cu(II), Cu(I), or Ni(II) bound at the active site, but does not occur upon 
Co(II) binding [78,79]. In contrast, biogenesis in apoAGAO is supported by Co(II) in addition to Cu(II) 
and Ni(II) (Cu(I) has not been tested) [77]. In both apoCAOs, Zn(II) binding at the active site renders 
the enzyme inert, as it does not support biogenesis and furthermore resists displacement by Cu(II) 
[75,77].  Several  properties  are  thought  to  contribute  to  a  metal’s  ability  to  initiate  and  support 
biogenesis in apoCAOs. The low reduction potentials for the Ni(II)/Ni(I) and Co(II)/Co(I) couples 
disfavor a mechanism requiring the reduction of the metal for biogenesis [80,81]. Lewis acidity has 
been proposed to be important for biogenesis; however Zn(II), an effective Lewis acid, is unable to 
support TPQ synthesis, suggesting that reduction potential does play some role in determining which 
metals can initiate biogenesis [75,77]. 
Figure 6. Active sites of (A) Co(II)-apoHPAO-1 (PDB code 3sxx) and (B) Co(II)-apoAGAO 
(PDB  code  1wmp)  [71,77].  Residues  are  drawn  in  stick  and  colored  by  atom  type 
(apoHPAO1:  carbon,  grey;  apoAGAO:  carbon,  green).  Cobalt  ions  are  drawn  as  pink 
spheres,  and  a  water  molecule  as  a  small  red  sphere.  Ligand-metal  interactions  are 
indicated by solid lines. Figure adapted from [71]. 
 
The  crystal  structures  of  apoHPAO-1,  Cu(I)-apoHPAO-1  (prepared  anaerobically)  and  Co(II)- 
apoHPAO-1 have also been reported [71]. The active sites of apoHPAO-1 and Cu(I)-apoHPAO-1 are 
nearly  superimposable  with  those  of  apoAGAO  and  Cu(II)-apoAGAO,  respectively  [58,69].  The 
structure of Co(II)-apoHPAO-1, however, reveals that cobalt binds in apoHPAO-1 and apoAGAO Int. J. Mol. Sci. 2012, 13  5387 
 
 
with different geometries (Figure 6). In apoHPAO-1, the cobalt is 5-coordinate, bound in a distorted 
square pyramidal geometry by the imidazole groups of three histidine residues, the precursor tyrosine 
residue,  and  an  equatorial  water  molecule  (Figure  6A)  [71].  In  contrast,  cobalt  in  the  apoAGAO 
structure is bound tetrahedrally by the three conserved histidine residues and the precursor tyrosine 
residue (Figure 6B) [77]. Given that Co(II) supports biogenesis in apoAGAO but not apoHPAO-1, it is 
likely that differences in metal coordination influence the ability of Co(II) to support biogenesis. 
Biogenesis requires precise control in terms of positioning the precursor tyrosine residue and the 
intermediates formed during biogenesis within the active site. These species undergo rotations about 
their Cα-Cβ and Cβ-Cγ bonds to occupy both on- and off-copper positions. A number of active site 
residues, including some within the consensus sequence which contains the precursor tyrosine residue, 
contribute  to  this  high  level  of  conformational  regulation  by  stabilizing  the  emerging  cofactor  in 
conformations accessed during biogenesis (Figure 7). 
A  strictly  conserved  active  site  tyrosine  residue  (Tyr305  in  HPAO-1)  is  involved  in  a  short 
hydrogen bond with the O4 atom of TPQ, helping to stabilize it in the appropriate position for catalysis 
of amine oxidation. The mutation of Tyr305 to a phenylalanine residue interferes with normal O–O 
bond cleavage during biogenesis and results in indiscriminant oxidative damage, indicating that this 
strictly conserved residue plays a role in conformational stabilization of the precursor tyrosine residue 
during biogenesis as well [82]. In HPAO-1, the mutation of the strictly conserved residue N-terminal to 
the precursor tyrosine (Asn404) to an alanine results in only 5-10% TPQ formation relative to the 
native  enzyme,  while  the  mutation  of  Asn404  to  an  aspartate  results  in  a  2-fold  decrease  in  
kTPQ [72,83]. The rate of TPQ biogenesis is also decreased by an order of magnitude when the residue  
C-terminal to the precursor tyrosine in HPAO-1 (Glu406) is mutated to a glutamine [72]. These effects 
illustrate the importance of the chemical properties of active site residues for biogenesis, such that 
mobility of the precursor tyrosine side chain is enabled during certain biogenesis steps, whereas a 
particular conformer is stabilized during others. 
Figure 7. Amino acid residues in apoHPAO-1 shown to be involved in stabilizing biogenesis 
intermediates (PDB code 3sx1) [71]. Residues are drawn in stick and colored by atom type 
(carbon,  grey).  A  water  molecule  is  drawn  as  a  small  red  sphere.  Dashed  lines  indicate 
hydrogen bonds. 
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The TPQ cofactor provides a chromophoric handle that enables changes in the electronic properties 
of  TPQ  to  be  monitored.  ApoCAO  protein  is  colorless  with  no  near-UV/visible  absorption  peak, 
whereas the mature protein is yellow-pink in color (λmax = 480 nm) due to electronic transitions within 
the  cofactor  [84].  When  apoHPAO-1  is  aerobically  reconstituted  with  Cu(II),  an  intermediate 
absorbing at 380 nm forms and decays before the formation of the species at 480 nm which indicates 
mature TPQ (Figure 8). The rates of formation and decay of the 380 nm species are unaffected by  
pre-incubation with zinc or the addition of Cu(II) to the mature TPQ-containing HPAO-1. Thus, this 
species is thought to arise from an off-pathway LMCT interaction [72]. 
Figure  8.  Solution  UV/visible  spectra  showing  the  time  course  of  the  aerobic 
reconstitution  of  apoHPAO-1  with  Cu(II)  at  pH  7.0.  The  directions  of  change  for  
near-UV/visible absorbance features over time are indicated by arrows. Figure from [71]. 
 
The copper bound at the CAO active site is ligated by three N and one/two O ligands and thus is 
type  2  or  ―non-blue‖  copper.  Consequently,  the  intense  spectral  feature  absorbing  at  ~600  nm 
associated with type 1 ―blue‖ copper sites (ε = ~5000 M
−1· cm
−1) due to the presence of a cysteinic 
sulfur  ligand  is  absent  in  CAOs  [85].  The  coupling  of  X-ray  crystallography  with  single  crystal 
spectroscopy is a powerful tool, allowing chromophoric species formed during enzymatic reactions to 
be identified before, during, and after X-ray data collection. 
7. Catalysis in CAOs 
Catalysis  in  CAOs  utilizes  a  ping-pong  mechanism  and  can  be  thought  of  as  two  distinct  
half-reactions: (1) the oxidation of a primary amine substrate, generating product aldehyde and the  
2-electron reduced aminoquinol form of the cofactor in which O5 is displaced by a substrate-derived 
amine group (known as the reductive half-reaction) and (2) the re-oxidation of TPQ with concomitant 
reduction of O2 to H2O2 and the release of NH4
+ (known as the oxidative half-reaction) (Scheme 3). Int. J. Mol. Sci. 2012, 13  5389 
 
 
Scheme 3. The catalytic half-reactions of CAOs. TPQamq, aminoquinol. E, enzyme. 
 
Scheme 4. Proposed CAO catalytic mechanism. RCH3NH3
+ is representative of all primary 
amine substrates. 
 
The  active  sites  of  resting  native  CAOs  contain  oxidized  TPQ  and  Cu(II)  (A  in  Scheme  4). 
Catalysis is initiated through the nucleophilic attack by a primary amine on the C5 atom of TPQ 
forming a covalent substrate Schiff base complex (A→B in Scheme 4) [86]. Proton abstraction by a 
conserved aspartate residue from the C1 atom of the substrate, which is expected to have a decreased 
pKa, forms the corresponding product Schiff base species (D in Scheme 4) via the rapid rearrangement 
of a carbanionic intermediate (C→D in Scheme 4) [87]. Hydrolysis of the product Schiff base releases 
the  corresponding  aldehyde  product  and  leaves  the  cofactor  as  a  2-electron  reduced  aminoquinol 
(D→E in Scheme 4) [88]. 
The aminoquinol represents the conclusion of the reductive half-reaction, and acts as the initial 
species in the oxidative half-reaction. While the study of CAOs from several sources has led to a 
general consensus regarding the reductive half-reaction, details concerning the oxidative half-reaction 
have remained unclear, particularly concerning the nature of the first electron transfer from reduced 
cofactor to O2 [89]. Reduced TPQ exists in an equilibrium between the aminoquinol/Cu(II) couple and 
a semiquinone radical/Cu(I) form (E and F, respectively, in Scheme 4) [90]. The distribution of the 
aminoquinol/semiquinone equilibrium is source-, pH-, and temperature-dependent [91–93]. At pH 7, 
CAOs derived from plant sources form as much as 40% semiquinone when anaerobically reduced with Int. J. Mol. Sci. 2012, 13  5390 
 
 
substrate, while other non-plant eukaryotic CAOs contain very low levels of semiquinone nearing the 
limit of detection [91]. Bacterial CAOs contain semiquinone at levels somewhere in between those of 
the two eukaryotic groups. 
Two proposals to describe the first electron transfer to O2 have been put forth. The first utilizes an 
inner  sphere  electron  transfer  mechanism,  in  which  O2  binds  to  the  reduced  copper  in  the 
semiquinone/Cu(I)  couple.  This  is  followed  by  electron  transfer  from  Cu(I)  to  O2  to  form 
copper(II)/superoxide. The transfer of another electron from the semiquinone and two protons to the 
superoxide yields the iminoquinone form of cofactor (G in Scheme 4) and hydrogen peroxide [94]. 
Support for an inner sphere electron transfer mechanism derives from the detection of the semiquinone 
radical form of TPQ [90] and the demonstration of a catalytically competent electron transfer rate from 
the aminoquinol to Cu(II) [93,95]. Additionally, azide, which is expected to ligate copper, was found 
to exhibit competitive inhibition with respect to O2 in PSAO and a CAO isolated from pig plasma, as 
well as partially competitive inhibition in DAO [96,97]. 
An outer sphere electron transfer mechanism has also been proposed, in which an electron from 
aminoquinol is transferred directly to O2 bound in a nearby hydrophobic pocket, forming superoxide 
and the semiquinone [98,99]. This mechanism does not involve an obligate change in the oxidation 
state of the copper, with its primary role being to stabilize the resultant superoxide. A kinetic study 
using BSAO demonstrated that the single electron reduction of O2 is rate-limiting during the oxidative 
half-reaction [98]. Chemical intuition suggests that this should be a fast process if the electron is 
derived from reduced Cu(I), thus an outer sphere electron transfer mechanism consistent with the 
kinetic data was proposed. Major support for an outer sphere electron transfer mechanism derives from 
work done with HPAO-1 [99,100]. The removal of copper from the HPAO-1 active site followed by 
reconstitution  with  Co(II)  resulted  in  fully-functional  protein  with  kinetic  parameters  under  
O2-saturating  conditions  indistinguishable  from  those  of  the  native  enzyme  [100].  In  addition,  
copper-depleted lentil seedling amine oxidase (LSAO) which was reconstituted with Co(II) regained 
partial catalytic competency [101]. The reduction potential of the Co(II)/Co(I) couple is very low, for 
example −400 to −500 mV vs. SHE in methionine synthase [80]. Co(II) is thus unlikely to be reduced 
during Co(II)-mediated catalysis, suggesting that a redox role for copper is unnecessary in the native 
enzyme. The use of a hydrophobic oxygen binding site near the copper is supported by kinetic data 
indicating that oxygen binding in HPAO-1 is noncompetitive with azide predicted to bind at the active 
site copper [102]. In addition, the oxidation of a model compound for the reduced cofactor has been 
shown  to  occur  in  the  absence  of  metal  [99].  Finally,  the  semiquinone  intermediate  in  some 
anaerobically  reduced  CAOs  is  virtually  undetectable,  which  lends  additional  support  to  an  outer 
sphere electron transfer mechanism [98]. 
The issue of the first electron transfer from cofactor to O2 is being actively pursued, and it has been 
suggested that CAOs may be capable of using more than one mechanism to reduce O2 but that each 
different CAO has a clear preference for either inner or outer sphere electron transfer [89,103,104]. 
Regardless, O2 ultimately accepts two electrons and two protons from the cofactor, yielding H2O2 and 
the iminoquinone (G in Scheme 4). Hydrolysis of the iminoquinone releases product ammonium and 
regenerates oxidized TPQ  (G→A in  Scheme 4).  Alternatively,  when substrate levels  are high  the 
iminoquinone can react with a second amine substrate, releasing product ammonium and generating 
the substrate Schiff base (G→B in Scheme 4). Int. J. Mol. Sci. 2012, 13  5391 
 
 
Catalysis in CAOs can be monitored spectroscopically owing to changes in the electronic form of 
TPQ, both in solution and in crystallo (Table 2). 
Table 2. λmax of spectroscopic intermediates formed during CAO catalysis. 
Catalytic Intermediate  λmax 
TPQ (quinone) [105]
  480 
Substrate Schiff base [106]  340 
Product Schiff base [83,107,108]
  380 
Aminoquinol [106]  310 
Semiquinone [90]  360, 435, 465 
Iminoquinone [109,110]
  450 or 350 (if charge is delocalized, as in HPAO-1) 
Cu(II)-peroxy [109]  410 
A  number  of  catalytic  intermediates  formed  during  both  half-reactions  have  been  structurally 
characterized. The active sites from structures  of native TPQ-containing CAOs  from a variety of 
organisms (Table 1) are nearly identical, and contain oxidized TPQ, copper ligated by the imidazole 
groups of three strictly conserved histidine residues, an aspartate residue which acts as the catalytic 
base during catalysis, and several conserved water molecules. The active site structure of HPAO-1 is 
shown in Figure 9A [64]. As described previously, catalytically productive TPQ in the native enzyme 
is in an off-copper conformation with its C5 carbonyl pointed toward the substrate amine channel, 
ideally positioned for attack by a primary amine substrate. This conformation is stabilized by hydrogen 
bonding between the O2 atom of TPQ and an axial water molecule (Wa in Figure 9A), and between the 
O4 atom of TPQ and the hydroxyl of a conserved tyrosine residue. Results from resonance Raman 
spectroscopy using AGAO indicate that underivatized TPQ exhibits significant electron delocalization 
between  the  C2  and  C4  oxygen  atoms,  with  only  the  C5  atom  possessing  significant  C=O  
character  [111]. This  is consistent  with  the formation  of a covalent cofactor-substrate Schiff base 
complex following nucleophilic attack at the C5 position during catalysis as opposed to the C2 or  
C4 positions.  
The structure of ECAO in a covalent complex with the inhibitor 2-hydrazinopyridine has been 
solved to a resolution of 2.0 Å [86] (Figure 9B). The inhibitor was found to bind to atom C5 of the 
cofactor,  displacing  the  O5  atom  and  generating  a  Schiff  base  analog  (B  in  Scheme  4).  Because  
2-hydrazinopyridine contains a nitrogen atom instead of a carbon at the C1 position, the covalent 
complex formed with the inhibitor cannot be deprotonated and thus accumulates in the crystal. The 
pyridine and quinone rings are not coplanar, suggesting that the complex is an analog of the substrate 
Schiff base and not the product Schiff base. A notable feature of this structure is the hydrogen bond 
between a nitrogen atom (corresponding to C1 in a physiological Schiff base) of the inhibitor/cofactor 
complex and an active site strictly conserved aspartate residue, which suggested this residue as the 
general catalytic base in the reductive half-reaction that abstracts a proton from the substrate Schiff 
base [86]. This was unequivocally confirmed through the study of twelve amino acid variants at this 
site in ECAO, which established that only glutamic acid had catalytic activity, although its kcat was 
reduced by a factor of 6.4 ×  10
4 compared to the native aspartic acid [86,87]. Recently, AGAO has 
also  been  solved  in  complex  with  three  different  hydrazine  inhibitors:  benzylhydrazine,  Int. J. Mol. Sci. 2012, 13  5392 
 
 
4-hydroxybenzylhydrazine, and phenylhydrazine [112]. As in ECAO, these bind as hydrazone adducts 
analogous to substrate Schiff base. 
The mutation of the active site aspartate residue (D298) to an alanine in AGAO results in a decrease 
in catalytic efficiency by ~10
6 orders of magnitude, with the low level of activity possibly due to water 
acting as a base [113]. The incubation of D298A AGAO crystals with the physiological substrate  
2-phenylethylamine for one week before freeze-trapping and structure solution resulted in a 1.85 Å 
resolution crystal structure containing a product Schiff base intermediate (Figure 9C). This assignment 
was confirmed by single crystal microspectrophotometry [113]. The product Schiff base has not been 
observed in solution, presumably due to the fast rate of hydrolysis which produces aldehyde and the 
aminoquinol (D→E in Scheme 4). In the crystal, however, the reaction is considerably slower and the 
product Schiff base is able to accumulate. The C2 atom of the product is coplanar with the TPQ ring 
and the imine double bond in this structure, which is anticipated for the product Schiff base formed 
with 2-phenylethylamine (Figure 9C). 
Figure  9.  Structurally  characterized  intermediates  formed  during  the  CAO  reductive  
half-reaction. (A) native HPAO-1 active site (PDB code 2oov) [64]; (B) ECAO containing 
a substrate Schiff base analog formed with the inhibitor 2-hydrazinopyridine (PDB code 
1spu) [86]; (C) D298A AGAO containing product Schiff base (PDB code 2cwv) [113]; (D) 
substrate-reduced ECAO containing the aminoquinol (PDB code 1d6u) [88]. Residues are 
drawn in stick and colored by atom type (carbon, grey). Copper ions are drawn as gold 
spheres, and water molecules as small red spheres. Dashed lines indicate hydrogen bonds, 
and solid lines indicate metal-ligand interactions. 
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The 2-electron reduced aminoquinol is the final cofactor intermediate formed during the reductive 
half-reaction,  and  marks  the  initiation  of  the  oxidative  half-reaction.  Crystals  containing  the 
aminoquinol at the active site were obtained by freeze-trapping crystals of ECAO after their anaerobic 
reduction with 2-phenylethylamine. The structure of this species was solved to a resolution of 2.4 Å 
(Figure  9D)  [88].  Single  crystal  microspectrophotometry  indicated  that  the  species  was  bleached, 
which is consistent with the aminoquinol (Table 2) [106]. Present in the off-copper conformation, the 
aminoquinol  interacts  with  the  copper  ion  through  the  axial  water  molecule  seen  in  native  CAO 
structures. A surprising feature in this structure was the presence of phenylacetaldehyde product bound 
at the back of the active site. Crystal contacts appeared to inhibit interdomain movement such that 
aldehyde remained trapped in the enzyme at the back of the active site [88]. 
Intermediates formed during the oxidative half-reaction which have been structurally characterized 
are shown in Figure 10. The oxidative half-reaction involves the reoxidation of TPQ, and begins with 
TPQ  in  an  equilibrium  between  the  aminoquinol/Cu(II)  couple  and  a  semiquinone  radical/Cu(I) 
species. A structure containing the aminoquinol has been solved, and is described in the preceding 
paragraph. Currently there is no published crystal structure of a reduced CAO containing semiquinone 
and Cu(I). 
Figure  10.  Structurally  characterized  intermediates  formed  during  the  CAO  oxidative  
half-reaction. (A) Substrate reduced ECAO containing the aminoquinol (PDB code 1d6u) [88]. 
(B) ECAO containing the iminoquinone (PDB code 1d6z) [88]. Residues are drawn in stick 
and colored by atom type (carbon, grey). Copper ions are drawn as gold spheres, and water 
molecules as small red spheres. Hydrogen bonding interactions are indicated by dashed 
lines, and metal-ligand interactions are indicated by solid lines. 
 
A structure of the iminoquinone intermediate formed during catalysis was solved after the prolonged 
aerobic  exposure  of  an  ECAO  crystal  to  2-phenylethylamine  (Figure  10B)  [88].  This  steady-state 
structure contains not only the iminoquinone, but also an oxygen species which has displaced the axial 
water  molecule  in  the  structure  containing  aminoquinol  (Figure  10A).  Phenylacetaldehyde  
product  remains  bound  in  the  back  of  the  active  site  in  the  same  position  it  occupies  in  the 
aminoquinol-containing structure (Figure 10A). The side-on geometry of the oxygen species in the 
presence  of  iminoquinone  and  product  aldehyde  suggested  that  this  was  most  likely  the  product Int. J. Mol. Sci. 2012, 13  5394 
 
 
hydrogen peroxide. The presence of an oxygen species bound at the copper coincident with product 
aldehyde demonstrates that in the crystal, the ping-pong kinetics seen in solution have been disrupted. 
Finally, it is well documented that CAOs function as obligate dimers, and evidence suggests that 
some, but not all, CAOs exhibit cooperativity through long-range conformational changes propagated 
through the CAO dimer from one active site to the other [86,114–118]. BSAO and ANAO exhibit  
half-site reactivity with regard to hydrazine inhibitors [114,115,118]. In addition, kinetic work using 
HPAO-1 heterodimers which contain zinc bound in one active site of the HPAO-1 dimer and copper in 
the second, could not efficiently carry out the oxidative half-reaction at either active site, suggesting 
that communication between the two metal binding sites influences oxidative chemistry [119]. It has 
been suggested that metal binding in one CAO active site induces conformational changes through a 
network of interactions that crosses the dimer interface [119]. 
8. CAO Channels and Access to the Active Site 
The substrates consumed during CAO catalysis (a primary amine and O2) take different paths to the 
same deeply-buried active site. A distinct substrate amine channel leads from the enzyme surface to 
the C5 atom of TPQ, the site of nucleophilic attack during catalysis (a distance of ~18 Å in HPAO-1) 
(Figure 11B). Despite the well-conserved structural homology of the overall CAO fold, the dimensions 
and shape of the amine substrate channel vary significantly depending on enzyme source. Amongst 
CAO homologs, only four amino acids within this channel display any sequence homology (besides 
the invariant aspartate residue which acts as the catalytic base and the consensus sequence containing 
the  precursor  tyrosine  residue  which  is  converted  to  TPQ).  Position  323  (HPAO-1  numbering) 
corresponds to an aromatic residue, position 155 corresponds to either a proline or serine residue, 
position 305 corresponds to a tyrosine residue important in stabilizing TPQ species and off-copper 
conformations, and position 156 corresponds to a bulky hydrophobic residue. This channel not only 
allows substrate amine access to the site of catalytic turnover, but also functions as an egress for 
product aldehyde exiting the active site. 
Substrate preference in different CAOs is also determined by the chemical properties of the residues 
lining the amine substrate/aldehyde product channel, as well as the general shape and size of the 
channel. These vary significantly depending on enzyme source, with channels ranging from nearly 
obstructed (ECAO, Figure 11A) to channels so broad that entire peptides can be accommodated and 
serve as substrates ((I) ANAO and (J) PPLO, Figure 11). 
An  additional  proposed  role  for  the  residues  lining  the  amine  substrate  channel  involves  the 
stereospecificity  of  the  proton  abstraction  step  during  the  CAO  reductive  half-reaction.  The 
stereospecificity  varies  depending  on  enzyme  source  and  the  identity  of  the  amine  substrate  
used  [86,120–122].  For  example,  PSAO  selectively  abstracts  the  pro-S  proton  from  dopamine, 
tyramine,  and  benzylamine  during  the  reductive  half-reaction,  while  BSAO  is  non-stereoselective 
when dopamine or tyramine are used as a substrate, but abstracts the pro-S proton from Schiff base 
complexes  formed  with  benzylamine,  p-hydroxybenzylamine,  and  3-methylbutylamine  [120,121].  
In contrast, AGAO is known to selectively abstract the  pro-S proton from Schiff base complexes 
formed with all substrates tested thus far [122]. In all CAO homologs, the pro-S proton from the Schiff 
base species formed with benzylamine is abstracted in favor of the pro-R proton. Given the strong Int. J. Mol. Sci. 2012, 13  5395 
 
 
structural homology between CAO active site residues, it has been suggested that the conformation of 
the substrate Schiff base complex itself is more important than the positions of active site residues 
relative to the amine substrate in determining the stereospecificity of the proton abstraction step [123]. 
The residues lining the amine substrate channel are important for the accommodation of Schiff base 
intermediates and display relatively low sequence homology amongst CAOs compared to other regions 
of the protein. The interactions between these residues and the Schiff base complexes consequently 
influence  the  stereospecificity  of  the  proton  abstraction  step  during  catalysis  in  a  species-  and/or 
substrate-dependent manner. 
Figure 11. Cross-section through the amine substrate channels of different CAOs. Each 
enzyme is drawn as a molecular surface. TPQ is drawn in stick and colored by atom type 
(carbon,  white).  Copper  ions  are  drawn  as  gold  spheres.  (A)  ECAO;  (B)  HPAO-1;  
(C)  HPAO-2; (D)  VAP-1; (E)  DAO; (F)  PSAO;  (G)  AGAO;  (H)  BSAO; (I)  ANAO;  
(J) PPLO (Table 1). 
 
The second substrate consumed during catalysis, molecular oxygen, had previously been thought to 
travel to the CAO active site via the ―inland lake‖ where the two monomers in the CAO dimer meet. 
While it is possible that the inland lake may act as a reservoir for molecular oxygen (based on potential 
of mean force (PMF) maps which illustrate regions of low free energy for the placement of O2 inside 
the protein matrix) it has been proposed that the narrow polar channel connecting this region to the 
active site is more appropriate for exiting H2O2 [64]. This is consistent with both the short length and 
polar nature of H2O2. 
In order to visualize molecular oxygen movement through the protein matrix, crystal structures of 
the complex between CAO and xenon have been solved from several sources, including PSAO [124], 
PPLO [124], ECAO [125], AGAO [124], and HPAO-1 [64]. Xenon has the same volume as molecular 
oxygen and mimics oxygen binding in hydrophobic pockets. Several recurrent O2 binding sites have Int. J. Mol. Sci. 2012, 13  5396 
 
 
been identified from these xenon complexes, including in the β-sheet sandwich fold of the catalytic D4 
domain, the amine substrate channel, and a channel from the inland lake. 
Figure 12. Overlay of xenon binding sites in xenon/CAO complexes. Domain D4 from one 
HPAO-1 monomer is drawn as a green cartoon, and active site residues are depicted in 
stick and colored by atom type (carbon, white). Xenon atoms are drawn as spheres and 
colored by enzyme source (PSAO, red; PPLO, yellow; AGAO, blue; HPAO-1, magenta). 
Arrows indicate the direction of O2 movement toward the active site. Figure from [64]. 
 
Taken together, crystallographic and PMF data from these studies suggest several species-dependent 
O2 points of entry into the protein interior (two are shown as black arrows in Figure 12). After its initial 
entry into the protein matrix, O2 is transiently held within the hydrophobic interior of domain D4, 
followed by migration closer to the active site where it is activated (Figure 12). Though the interior of 
domain  D4  is  largely  composed  of  hydrophobic  residues  in  all  CAO  homologs,  source-specific 
differences in the primary amino acid sequence of D4 could account for the different points of entry 
utilized by O2 in different CAO homologs. 
9. Summary 
The studies on CAOs demonstrate the power and complementarity of X-ray crystallography in 
understanding catalytic processes when combined with kinetic analysis, mutagenesis and spectroscopy, 
both in solution and in the crystal. The crystalline environment can dramatically slow down the rates of 
catalytic steps that depend on enzyme dynamics, and even alter the catalytic mechanism, as seen in the 
loss of ping-pong kinetics in ECAO catalysis in crystallo. However, when coupled to complementary 
single crystal spectroscopy any structural changes can effectively be equated to catalytic intermediates 
observed spectroscopically in solution. X-ray crystallography has been, and will remain, an important 
tool in the quest for understanding both CAO biogenesis and catalysis at the molecular level. 
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